Indeed, transcriptional deregulation is thought to drive malignant transformation in soft-tissue sarcomas harboring oncogenic fusions of FET genes with site-specific transcription factors, such as CHOP, FLI1, and CREB (4, 85, 86). The gene discussed is FLI1; the disease is soft tissue sarcoma.